Hovione Expands CDMO Capabilities with Major Upgrades in Europe and the USA Facilities

• Hovione has expanded its facilities in Cork, Ireland, and East Windsor, New Jersey, significantly increasing global spray drying capacity.

• The investment creates over 40 skilled jobs and bolsters the company’s ability to deliver advanced drug manufacturing solutions.

Hovione, an integrated CDMO specialising in spray drying and particle engineering, has completed significant upgrades to its East Windsor, New Jersey, and Ringaskiddy, Cork, sites. These expansions enhance the company’s ability to deliver cutting-edge contract manufacturing solutions while creating over 40 skilled jobs.

The investment in New Jersey marks the start of a multi-year program to improve both spray drying and tableting capabilities. Meanwhile, the Cork site’s spray drying capacity has nearly doubled, reinforcing Hovione’s position as a leader in pharmaceutical spray drying. This advanced technology plays a pivotal role in improving drug solubility and bioavailability, crucial for inhalable therapies and oral medications.

“These expansions, incorporating our latest technologies, reflect Hovione’s unwavering commitment to innovation and manufacturing service excellence,” said Dr Jean-Luc Herbeaux, Chief Executive Officer of Hovione. “Strengthening our facilities and teams in the USA and Ireland allows us to better serve our customers and provide flexible supply options for both small- and large-scale programs.”

Spray drying technology is increasingly critical for pharmaceutical applications, particularly for developing treatments with poorly water-soluble drugs. By converting liquid solutions into fine powders, the process enhances dissolution, absorption, and therapeutic efficacy, ensuring better outcomes for patients.

Hovione’s investments align with its 65-year history of innovation and continuous improvement. The upgrades underscore its long-term commitment to remaining at the forefront of pharmaceutical development and manufacturing, ensuring reliable solutions for complex drug delivery challenges.